Pete Oliver represents NATA at the recent Cambridge New Therapeutics Forum
NATA was proud to participate in the Cambridge New Therapeutics Forum (CamNTF), held last month at the University of Cambridge. This event aims to strengthen collaboration between scientists in academia and industry, fostering opportunities for innovative biotechnology research and development.
Recently, our Head of Biology, Pete, has participated in the Cambridge New Therapeutics Forum. This meeting included speakers such as Mark Edbrooke, an independent scientific consultant; Dan Swerdlow, Senior Director of Discovery Medicine at GSK; and Catherine Wilson, Lecturer at the Department of Pharmacology, University of Cambridge. The forum, hosted by Alex Samoshkin, Deputy Head of the Office for Translational Research at the Maxwell Centre, brought together an audience of academics, clinicians, and industry representatives.
NATA is excited to be part of this initiative, building strong translational bridges between academia and industry, working alongside the University of Cambridge and other leading industry partners. Our involvement reflects our ongoing commitment to advancing healthcare research and developing new innovative therapeutics for patients.